BerandaLCTX • NYSEAMERICAN
add
Lineage Cell Therapeutics Inc
$0,42
Setelah Jam Perdagangan Normal:(6,19%)+0,026
$0,44
Tutup: 16 Apr, 19.59.54 GMT-4 · USD · NYSEAMERICAN · Pernyataan Penyangkalan
Tutup sebelumnya
$0,43
Rentang hari
$0,42 - $0,45
Rentang tahun
$0,37 - $1,40
Kapitalisasi pasar
94,94Â jt USD
Volume Rata-Rata
1,69Â jt
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Des 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 2,87Â jt | 37,36% |
Biaya operasional | 4,40Â jt | 480,61% |
Laba bersih | -3,27Â jt | 31,46% |
Margin laba bersih | -114,12 | 50,10% |
Penghasilan per saham | -0,01 | 63,24% |
EBITDA | -4,96Â jt | -86,64% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
(USD) | Des 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 47,80Â jt | 34,69% |
Total aset | 113,22Â jt | 12,08% |
Total liabilitas | 36,21Â jt | -7,15% |
Total ekuitas | 77,01 jt | — |
Saham yang beredar | 228,36 jt | — |
Harga terhadap nilai buku | 1,19 | — |
Tingkat pengembalian aset | -12,18% | — |
Tingkat pengembalian modal | -17,37% | — |
Arus Kas
Perubahan kas bersih
(USD) | Des 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | -3,27Â jt | 31,46% |
Kas dari operasi | -6,35Â jt | -5,43% |
Kas dari investasi | 2,64Â jt | -72,95% |
Kas dari pembiayaan | 21,73Â jt | 167.284,62% |
Perubahan kas bersih | 18,05Â jt | 352,10% |
Arus kas bebas | -3,50Â jt | -594,59% |
Tentang
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Didirikan
1990
Situs
Karyawan
74